SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001387131-20-003461
Filing Date
2020-03-30
Accepted
2020-03-30 17:15:55
Documents
3
Period of Report
2020-05-01
Effectiveness Date
2020-03-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tnxp-def14a_050120.htm DEF 14A 953747
2 GRAPHIC proxycard-img_001.jpg GRAPHIC 299762
3 GRAPHIC proxycard-img_0002.jpg GRAPHIC 287518
  Complete submission text file 0001387131-20-003461.txt   1763933
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 20758315
SIC: 2834 Pharmaceutical Preparations